AZ 628 is a potent, selective pan-Raf kinase inhibitor used extensively in oncological research to study signaling pathways, including the inhibition of BRAF and CRAF kinases. This category comprises the… Read more
AZ 628 is a potent, selective pan-Raf kinase inhibitor used extensively in oncological research to study signaling pathways, including the inhibition of BRAF and CRAF kinases. This category comprises the parent compound along with its stable isotope labelled versions, such as the trideuterated analog, which are essential for precise analytical applications. Pharmaceutical laboratories utilize these high-quality reference standards for rigorous impurity profiling, method validation, and accurate quantification in complex biological matrices. By providing reliable compounds for metabolic profiling and pharmacokinetic studies, these materials support the development of assays using high-resolution mass spectrometry. Whether investigating the mechanisms of tumor growth inhibition or supporting the characterization of kinase-driven pathways, these reference materials ensure consistency and accuracy in critical analytical testing and quality control procedures within the drug development lifecycle.